Skip to main content
Livermore
Livermore
ZHEN

Entrada Therapeutics, Inc.

TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001689375

In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Entrada Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
53
+6 vs. Q4 2022
Shares held
24.9M
+173.2K (+0.7%) vs. Q4 2022
Total value
$361.0M
+$26.9M (+8.0%) vs. Q4 2022
New holders
10
24 more added
Sold out
4
6 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TRDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 53 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 46 institutionsQ1 2022: 48 institutionsQ2 2022: 38 institutionsQ3 2022: 33 institutionsQ4 2022: 47 institutionsQ1 2023: 53 institutionsQ2 2023: 56 institutionsQ3 2023: 55 institutionsQ4 2023: 62 institutionsQ1 2024: 77 institutionsQ2 2024: 84 institutionsQ3 2024: 97 institutionsQ4 2024: 102 institutionsQ1 2025: 110 institutionsQ2 2025: 107 institutionsQ3 2025: 116 institutionsQ4 2025: 113 institutionsQ1 2026: 119 institutionsQ2 2026: 128 institutions
Value heldQ1 2023: $361.0M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $433.8MQ1 2022: $242.8MQ2 2022: $301.8MQ3 2022: $386.4MQ4 2022: $334.2MQ1 2023: $361.0MQ2 2023: $389.9MQ3 2023: $411.4MQ4 2023: $396.6MQ1 2024: $368.8MQ2 2024: $423.1MQ3 2024: $481.1MQ4 2024: $529.8MQ1 2025: $274.5MQ2 2025: $198.8MQ3 2025: $164.8MQ4 2025: $251.0MQ1 2026: $321.4MQ2 2026: $214.4M
Institutions holding TRDA and their total value by quarter
QuarterHoldersValue
Q2 2026128$214.4M
Q1 2026119$321.4M
Q4 2025113$251.0M
Q3 2025116$164.8M
Q2 2025107$198.8M
Q1 2025110$274.5M
Q4 2024102$529.8M
Q3 202497$481.1M
Q2 202484$423.1M
Q1 202477$368.8M
Q4 202362$396.6M
Q3 202355$411.4M
Q2 202356$389.9M
Q1 202353$361.0M
Q4 202247$334.2M
Q3 202233$386.4M
Q2 202238$301.8M
Q1 202248$242.8M
Q4 202146$433.8M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Entrada Therapeutics, Inc.; share changes are against Q4 2022.

Institutions holding TRDA in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Baker Bros. Advisors LP4,865,819$70.6M0.38%00.0%Unchanged
MPM Asset Management LLC4,425,784$64.2M26.74%00.0%Unchanged
5AM Venture Management, LLC4,408,379$63.9M16.35%00.0%Unchanged
Price T Rowe Associates Inc2,983,863$43.3M0.01%−30,514−1.0%Reduced
Redmile Group, LLC1,831,608$26.6M1.15%−22,500−1.2%Reduced
Wellington Management Group LLP1,014,453$14.7M0.00%+4,102+0.4%Added
Vanguard Group Inc928,665$13.5M0.00%+8,412+0.9%Added
StepStone Group LP761,277$11.0M2.05%00.0%Unchanged
TCG Crossover Management, LLC584,955$8.48M1.65%00.0%Unchanged
FMR LLC531,408$7.71M0.00%+27,497+5.5%Added
72 Investment Holdings, LLC509,023$7.38M3.50%00.0%Unchanged
BlackRock Inc.211,985$3.07M0.00%+23,991+12.8%Added
Laurion Capital Management LP199,066$2.89M0.13%00.0%Unchanged
Millennium Management LLC197,253$2.86M0.00%+157,359+394.4%Added
Susquehanna International Group, LLP196,513$2.85M0.00%+84,716+75.8%Added
Geode Capital Management, LLC183,790$2.66M0.00%+1,833+1.0%Added
Moore Capital Management, LP105,000$1.52M0.05%00.0%Unchanged
Charles Schwab Investment Management Inc89,478$1.30M0.00%+508+0.6%Added
Jane Street Group, LLC73,898$1.07M0.00%+59,374+408.8%Added
Nan Fung Group Holdings Ltd73,582$1.07M0.73%00.0%Unchanged
State Street Corp64,577$936.4K0.00%+54+0.1%Added
Citigroup Inc62,023$899.3K0.00%+10,981+21.5%Added
TD Asset Management Inc59,627$864.6K0.00%00.0%Unchanged
CHI Advisors LLC56,374$817.4K0.22%+56,374New
Manufacturers Life Insurance Company, The47,712$691.8K0.00%+6,506+15.8%Added
Goldman Sachs Group Inc47,176$684.1K0.00%−354,863−88.3%Reduced
Morgan Stanley41,768$605.6K0.00%+16,882+67.8%Added
Qube Research & Technologies Ltd38,782$562.3K0.00%+22,000+131.1%Added
HRT Financial LP38,395$556.0K0.01%+38,395New
Bank of America Corp33,771$489.7K0.00%+28,475+537.7%Added
Northern Trust Corp33,393$484.2K0.00%−967−2.8%Reduced
Natixis31,186$444.4K0.00%+5,000+19.1%Added
Swiss National Bank23,700$343.6K0.00%−2,800−10.6%Reduced
Marshall Wace, LLP17,327$251.2K0.00%+17,327New
LMR Partners LLP13,023$188.8K0.00%+13,023New
Nuveen Asset Management, LLC12,987$188.0K0.00%+12,987New
Bank of New York Mellon Corp12,439$180.4K0.00%00.0%Unchanged
Credit Suisse AG12,399$179.8K0.00%+3,588+40.7%Added
Man Group plc–$162.5K0.00%–New
683 Capital Management, LLC10,355$150.1K0.01%00.0%Unchanged
Barclays PLC10,228$148.3K0.00%−544−5.1%Reduced
Y-Intercept (Hong Kong) Ltd10,188$147.7K0.02%+10,188New
California State Teachers Retirement System9,631$139.7K0.00%+117+1.2%Added
JPMorgan Chase & Co8,540$124.0K0.00%+947+12.5%Added
Cubist Systematic Strategies, LLC4,160$60.3K0.00%+3,755+927.2%Added
Legal & General Group Plc3,574$51.8K0.00%+637+21.7%Added
Point72 Middle East FZE3,441$49.9K0.00%+3,441New
Point72 Asset Management, L.P.2,840$41.2K0.00%+2,840New
UBS Group AG1,457$21.1K0.00%+200+15.9%Added
Tower Research Capital LLC (TRC)1,292$19.0K0.00%+845+189.0%Added
Advisor Group Holdings, Inc.300$4.35K0.00%00.0%Unchanged
The PNC Financial Services Group, Inc.200$2.90K0.00%+200New
Wells Fargo & Company169$2.45K0.00%+1+0.6%Added
Ergoteles LLC0$00.00%−14,019−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−12,132−100.0%Sold out
State of Wisconsin Investment Board0$00.00%−10,971−100.0%Sold out
Royal Bank of Canada0$00.00%−28−100.0%Sold out